Iager A C, Kirch D G, Bigelow L B, Karson C N
Am J Psychiatry. 1986 Mar;143(3):375-7. doi: 10.1176/ajp.143.3.375.
Ten patients with chronic schizophrenia completed a 3-month double-blind, placebo-controlled trial with a vasopressin analogue. Modest improvement occurred, but several patients also experienced significant fluid and electrolyte imbalance.
十名慢性精神分裂症患者完成了一项为期三个月的、使用血管加压素类似物的双盲、安慰剂对照试验。病情有一定改善,但有几名患者也出现了明显的体液和电解质失衡。